Literature DB >> 25581706

Reversible lacrimal gland-protective regulatory T-cell dysfunction underlies male-specific autoimmune dacryoadenitis in the non-obese diabetic mouse model of Sjögren syndrome.

Scott M Lieberman1, Portia A Kreiger, Gary A Koretzky.   

Abstract

CD4(+) CD25(+) Foxp3(+) regulatory T (Treg) cells are required to maintain immunological tolerance; however, defects in specific organ-protective Treg cell functions have not been demonstrated in organ-specific autoimmunity. Non-obese diabetic (NOD) mice spontaneously develop lacrimal and salivary gland autoimmunity and are a well-characterized model of Sjögren syndrome. Lacrimal gland disease in NOD mice is male-specific, but the role of Treg cells in this sex-specificity is not known. This study aimed to determine if male-specific autoimmune dacryoadenitis in the NOD mouse model of Sjögren syndrome is the result of lacrimal gland-protective Treg cell dysfunction. An adoptive transfer model of Sjögren syndrome was developed by transferring cells from the lacrimal gland-draining cervical lymph nodes of NOD mice to lymphocyte-deficient NOD-SCID mice. Transfer of bulk cervical lymph node cells modelled the male-specific dacryoadenitis that spontaneously develops in NOD mice. Female to female transfers resulted in dacryoadenitis if the CD4(+) CD25(+) Treg-enriched population was depleted before transfer; however, male to male transfers resulted in comparable dacryoadenitis regardless of the presence or absence of Treg cells within the donor cell population. Hormone manipulation studies suggested that this Treg cell dysfunction was mediated at least in part by androgens. Surprisingly, male Treg cells were capable of preventing the transfer of dacryoadenitis to female recipients. These data suggest that male-specific factors promote reversible dysfunction of lacrimal gland-protective Treg cells and, to our knowledge, form the first evidence for reversible organ-protective Treg cell dysfunction in organ-specific autoimmunity.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  Sjögren syndrome; dacryoadenitis; non-obese diabetic mouse; regulatory T cells

Mesh:

Year:  2015        PMID: 25581706      PMCID: PMC4427388          DOI: 10.1111/imm.12439

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  45 in total

1.  High incidence of autoimmune dacryoadenitis in male non-obese diabetic (NOD) mice depending on sex steroid.

Authors:  M Takahashi; N Ishimaru; K Yanagi; N Haneji; I Saito; Y Hayashi
Journal:  Clin Exp Immunol       Date:  1997-09       Impact factor: 4.330

2.  Comment on: Tritt et al. (2007) Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes: Diabetes 57:113-123, 2007.

Authors:  David C Thomas; Richard J Mellanby; Anne Cooke
Journal:  Diabetes       Date:  2008-03       Impact factor: 9.461

Review 3.  Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease.

Authors:  Cuong Q Nguyen; Ammon B Peck
Journal:  Ocul Surf       Date:  2009-01       Impact factor: 5.033

4.  Non-obese diabetic mice select a low-diversity repertoire of natural regulatory T cells.

Authors:  Cristina Ferreira; Yogesh Singh; Anna L Furmanski; F Susan Wong; Oliver A Garden; Julian Dyson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

5.  Functional testosterone receptors in plasma membranes of T cells.

Authors:  W P Benten; M Lieberherr; G Giese; C Wrehlke; O Stamm; C E Sekeris; H Mossmann; F Wunderlich
Journal:  FASEB J       Date:  1999-01       Impact factor: 5.191

6.  Characterization of T cell receptor repertoire and anti-Ro/SSA autoantibodies in relation to sialadenitis of NOD mice.

Authors:  K Skarstein; M Wahren; E Zaura; M Hattori; R Jonsson
Journal:  Autoimmunity       Date:  1995       Impact factor: 2.815

7.  Continuous T cell receptor signals maintain a functional regulatory T cell pool.

Authors:  J Christoph Vahl; Christoph Drees; Klaus Heger; Sylvia Heink; Julius C Fischer; Jelena Nedjic; Naganari Ohkura; Hiromasa Morikawa; Hendrik Poeck; Sonja Schallenberg; David Rieß; Marco Y Hein; Thorsten Buch; Bojan Polic; Anne Schönle; Robert Zeiser; Annette Schmitt-Gräff; Karsten Kretschmer; Ludger Klein; Thomas Korn; Shimon Sakaguchi; Marc Schmidt-Supprian
Journal:  Immunity       Date:  2014-11-06       Impact factor: 31.745

8.  Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity.

Authors:  Janet G M Markle; Daniel N Frank; Steven Mortin-Toth; Charles E Robertson; Leah M Feazel; Ulrike Rolle-Kampczyk; Martin von Bergen; Kathy D McCoy; Andrew J Macpherson; Jayne S Danska
Journal:  Science       Date:  2013-01-17       Impact factor: 47.728

Review 9.  FOXP3 and scurfy: how it all began.

Authors:  Fred Ramsdell; Steven F Ziegler
Journal:  Nat Rev Immunol       Date:  2014-04-11       Impact factor: 53.106

10.  Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes.

Authors:  Shannon M Pop; Carmen P Wong; Donna A Culton; Stephen H Clarke; Roland Tisch
Journal:  J Exp Med       Date:  2005-04-18       Impact factor: 14.307

View more
  18 in total

1.  MSC-Derived Small Extracellular Vesicles Attenuate Autoimmune Dacryoadenitis by Promoting M2 Macrophage Polarization and Inducing Tregs via miR-100-5p.

Authors:  Na Li; Zhiqi Gao; Lu Zhao; Bei Du; Binyun Ma; Hong Nian; Ruihua Wei
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

2.  PPAR-α Agonist Fenofibrate Ameliorates Sjögren Syndrome-Like Dacryoadenitis by Modulating Th1/Th17 and Treg Cell Responses in NOD Mice.

Authors:  Xingyi Guo; Weiyu Dang; Na Li; Ying Wang; Deming Sun; Hong Nian; Ruihua Wei
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-06-01       Impact factor: 4.925

3.  Salivary-gland-protective regulatory T-cell dysfunction underlies female-specific sialadenitis in the non-obese diabetic mouse model of Sjögren syndrome.

Authors:  Jennifer Y Barr; Xiaofang Wang; Portia A Kreiger; Scott M Lieberman
Journal:  Immunology       Date:  2018-05-31       Impact factor: 7.397

Review 4.  The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research.

Authors:  Stephen C Pflugfelder; Cintia S de Paiva
Journal:  Ophthalmology       Date:  2017-11       Impact factor: 12.079

5.  CD8 T cells contribute to lacrimal gland pathology in the nonobese diabetic mouse model of Sjögren syndrome.

Authors:  Jennifer Y Barr; Xiaofang Wang; David K Meyerholz; Scott M Lieberman
Journal:  Immunol Cell Biol       Date:  2017-05-03       Impact factor: 5.126

6.  Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Tear Production in a Mouse Model of Sjögren's Syndrome.

Authors:  Hema S Aluri; Mahta Samizadeh; Maria C Edman; Dillon R Hawley; Helene L Armaos; Srikanth R Janga; Zhen Meng; Victor G Sendra; Pedram Hamrah; Claire L Kublin; Sarah F Hamm-Alvarez; Driss Zoukhri
Journal:  Stem Cells Int       Date:  2017-03-02       Impact factor: 5.443

7.  Tissue resident memory T cells in the human conjunctiva and immune signatures in human dry eye disease.

Authors:  Tanima Bose; Ryan Lee; Aihua Hou; Louis Tong; K George Chandy
Journal:  Sci Rep       Date:  2017-03-27       Impact factor: 4.379

8.  Endogenous programmed death ligand-1 restrains the development and onset of Sjӧgren's syndrome in non-obese diabetic mice.

Authors:  Jing Zhou; Jun-O Jin; Toshihisa Kawai; Qing Yu
Journal:  Sci Rep       Date:  2016-12-14       Impact factor: 4.379

Review 9.  Androgen-Induced Immunosuppression.

Authors:  Melanie R Gubbels Bupp; Trine N Jorgensen
Journal:  Front Immunol       Date:  2018-04-17       Impact factor: 7.561

10.  UBASH3A deficiency accelerates type 1 diabetes development and enhances salivary gland inflammation in NOD mice.

Authors:  Yi-Guang Chen; Ashley E Ciecko; Shamim Khaja; Michael Grzybowski; Aron M Geurts; Scott M Lieberman
Journal:  Sci Rep       Date:  2020-07-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.